Daniel Lin-Arlow is the founder of Ansa Biotechnologies. Ansa Biotechnologies has raised $86M in total funding. Latest round: Series A.
Daniel Lin-Arlow is the co-founder and CEO of Ansa Biotechnologies, a UC Berkeley spin-off founded in 2018. He grew the company from a two-person team in 2018 to 86 employees, raising over $86 million in venture capital and grants to fund development.
Full founder directory · Investor directory · Company funding database · Fundraising library